Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
APPENDIX C - GRAPHICAL REPRESENTATION OF ANSWERS TO SELECTED QUESTIONS BY RESPONDENTS TO THE QUESTIONNAIRE SURVEY (SEE APPENDIX A) | Significant Findings from Full-Scale Accelerated Pavement Testing | The National Academies Press
Clinician-rated measures for distal symmetrical axonal polyneuropathy | Neurology
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy | BMC Neurology | Full Text
The overall disability sum score (ODSS) | Download Table
Therapeutic Considerations for the Management of CIDP and MMN: Case Reviews
Incat Score Pdf - Fill Online, Printable, Fillable, Blank | pdfFiller
Chronic Inflammatory Demyelinating Polyneuropathy - Practical Neurology
Construction and validation of the chronic acquired polyneuropathy patient‐reported index (CAP‐PRI): A disease‐specific, health‐related quality‐of‐life instrument - Gwathmey - 2016 - Muscle & Nerve - Wiley Online Library
CAT Normalization Process 2023: How Scaled Score is Calculated, Revised Process for 3 Shifts | CollegeDekho
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses - Draak - 2015 - Journal of the Peripheral Nervous System - Wiley Online Library
Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy | Scientific Reports
Clinical characteristics from CIDP patients with INCAT disability... | Download Table
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. | Semantic Scholar
Frontiers | Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
03-Sep-19 1 PRACTICAL POINTS IN CIDP MANAGEMENT CONTENT CIDP KEY FEATURES
Number of responders by the adjusted INCAT score at completion (ITT). | Download Table
Changes in the Inflammatory Neuropathy Cause and Treatment (INCAT)... | Download Scientific Diagram
Mean adjusted Inflammatory Neuropathy Cause and Treatment (INCAT) score... | Download Scientific Diagram
Expanding the Role of the Pharmacist: Immunoglobulin Therapy and Disease Management in Neuromuscular Disorders | Semantic Scholar
Assessment of INCAT, ISS, and MRC Scales Before and After Treatment... | Download Scientific Diagram
Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. | Semantic Scholar
A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. - Abstract - Europe PMC
PDF) Validation of the Serbian version of inflammatory Rasch‐built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy | Mariëlle Pruppers - Academia.edu
Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. | Semantic Scholar
Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy | Journal of Neurology
